Keyphrases
Antibiotic Prophylaxis
100%
Cesarean Section (C-section)
100%
Cephalosporins
100%
Azithromycin
75%
Post-caesarean Infection
62%
Extended-spectrum
62%
Ureaplasma
50%
Specific Intent
40%
Neonatal Outcome
25%
Incision
25%
Non-elective
25%
Cesarean Delivery
25%
Endometritis
20%
Multidrug-resistant Organisms
12%
Adverse Neonatal Outcome
12%
Amniotic Fluid
12%
Multicenter Randomized Clinical Trial
12%
Multicenter Randomized Trial
12%
Clindamycin
12%
Chorioamnion
12%
Drug Reaction
12%
Narrow Spectrum
12%
Post-cesarean Section
12%
Systemic Inflammatory Response Syndrome
12%
CDC Guidelines
12%
Surgical Incision
12%
Unscheduled Cesarean Delivery
12%
Lower Genital Tract
12%
Single Center
12%
Common Bacteria
12%
Common Pathogens
12%
Maternal Outcomes
12%
Elective Cesarean
12%
Pregnancy-related Death
12%
Rupture of Membranes
12%
Galveston
12%
Umbilical Cord Blood
12%
Cefazolin
12%
Cesarean
12%
Surgical Site Infection
12%
Pneumonia
12%
Pyloric Stenosis
12%
Perinatal Center
12%
University of Texas
10%
Comparative Effectiveness
10%
Sepsis
10%
University of North Carolina
10%
Blood Fluid
10%
Risk Factors
10%
Biological Specimens
10%
Clinical Trials
10%
Comparative Safety
10%
High-risk Women
10%
Wound Infection
10%
Chapel Hill
10%
Obstetrics and Gynaecology
10%
Multicenter Clinical Trial
10%
Bronchopulmonary Dysplasia
10%
Antibiotics
10%
Neonatal Infection
10%
Public Health
10%
Infection Rate
10%
Illness
10%
Placebo
10%
Prenatal Exposure
10%
University of Alabama at Birmingham
10%
Medicine and Dentistry
Antibiotic Prophylaxis
100%
Cesarean Section
100%
Cephalosporin
88%
Infection
80%
Azithromycin
66%
Ureaplasma
44%
Incision
22%
Clinical Trial
17%
Endometritis
17%
Clindamycin
11%
Pylorus Stenosis
11%
Cefazolin
11%
Fetal Membrane
11%
Caesarean
11%
Surgical Infection
11%
Systemic Inflammatory Response Syndrome
11%
Single Drug Dose
11%
Prenatal Exposure
11%
Drug Hypersensitivity
11%
Surgical Incision
11%
Pathogen
8%
Randomized Clinical Trial
8%
Side Effect
8%
Specimen
8%
Wound Infection
8%
Amnion Fluid
8%
Disease
8%
Antibiotics
8%
Wound
8%
Newborn Infection
8%
Placebo
8%
Sepsis
8%
Lung Dysplasia
8%
Cord Blood
8%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Prophylaxis
100%
Cephalosporin
88%
Infection
80%
Azithromycin
66%
Ureaplasma
44%
Endometritis
17%
Clinical Trial
17%
Systemic Inflammatory Response Syndrome
11%
Newborn Infection
11%
Clindamycin
11%
Pylorus Stenosis
11%
Surgical Infection
11%
Membrane Rupture
11%
Cefazolin
11%
Lung Dysplasia
11%
Randomized Clinical Trial
8%
Placebo
8%
Wound Infection
8%
Wound
8%
Antibiotics
8%
Side Effect
8%
Infectious Agent
8%
Disease
8%
Prenatal Exposure
8%
Sepsis
8%